Answers are grounded in this paper and cite their sources.
Heterozygous carriers of autosomal recessive disease variants are often considered clinically unaffected, yet population biobanks can reveal measurable carrier phenotypes. MMACHC (MIM: 609831) encodes an intracellular cobalamin-processing protein. Bi-allelic MMACHC loss causes cobalamin C (cblC) disease, with methylmalonic acid (MMA) and homocysteine (Hcy) accumulation. Because Mmachc heterozygous mice show elevated MMA and Hcy,1 we asked whether MMACHC heterozygosity leaves a detectable biochemical signature in humans.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: